When was Rilutek approved by the FDA?

Written by Teresa Carvalho, MS |

A

When was Rilutek approved by the FDA?

Category: Rilutek

The U.S. Food and Drug Administration (FDA) approved Rilutek for the treatment of amyotrophic lateral sclerosis in 1995. Rilutek was the first medication to ever be approved in the country for the disease, but generics and other formulations of its active ingredient are now widely available.

Print This Page
Teresa Carvalho, MS avatar

About the Author

Teresa Carvalho, MS Teresa holds her Master of Science in cell and molecular biology from Coimbra University, Portugal. She was a researcher and science communicator for several years at the Institute for Research and Innovation in Health in Oporto, Portugal. From 2013, she has held a fellowship working with Pulmonary Hypertension Europe as a patient advocate, social media/website manager, public relations officer, and translator. Her work has been focused on providing patients access to treatments, raising awareness for pulmonary hypertension, and promoting patient empowerment.


Recommended reading